Article Versions Notes

Mahtani R, Niyazov A, Arondekar B, Lewis K, Rider A, Massey L, Lux MP. BRCA1/2 Mutation Testing in Patients with HER2-Negative Advanced Breast Cancer: Real-World Data from the United States, Europe, and Israel. Cancers. 2022; 14(21):5399. https://doi.org/10.3390/cancers14215399

Mahtani, Reshma, Alexander Niyazov, Bhakti Arondekar, Katie Lewis, Alex Rider, Lucy Massey, and Michael Patrick Lux. 2022. "BRCA1/2 Mutation Testing in Patients with HER2-Negative Advanced Breast Cancer: Real-World Data from the United States, Europe, and Israel" Cancers 14, no. 21: 5399. https://doi.org/10.3390/cancers14215399

Mahtani, R., Niyazov, A., Arondekar, B., Lewis, K., Rider, A., Massey, L., & Lux, M. P. (2022). BRCA1/2 Mutation Testing in Patients with HER2-Negative Advanced Breast Cancer: Real-World Data from the United States, Europe, and Israel. Cancers, 14(21), 5399. https://doi.org/10.3390/cancers14215399